Candida auris is an emerging fungus that presents a serious global health threat. CDC is concerned about C. auris for three main reasons:
- It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candidainfections.
- It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
- It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread.
CDC encourages all U.S. laboratory staff who identify C. auris to notify their state or local public health authorities and CDC at firstname.lastname@example.org.
- It causes serious infections.
- More than 1 in 3 patients with invasive C. auris infection die.
- It’s often resistant to medicines.
- It’s becoming more common.
- It’s difficult to identify.
- It can spread in hospitals and nursing homes.
Lastest information on the outbreaks – (subject to change)
- March 29, 2019: Case count updated to 617
- March 7, 2019: Updated Tracking Candida auris to reflect 2019 nationally notifiable status and updated case definition
- December 21, 2018: Updated recommendations for laboratorians and health professionals, including environmental disinfection, species identification, and screening recommendations; reorganized webpages
- July 20, 2018: Fact sheets added for patients, laboratory staff, and infection preventionists